http://orcid.org/0000-0002-9530-3383
References
- Skin Cancer Foundation: Skin Cancer Facts & Statistics [Internet]. The Skin Cancer Foundation, 2019. [cited 2019 Oct 21]. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/#nonmelanoma
- Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc. 2017;92(6):890–898.
- National Comprehensive Cancer Network: Squamous Cell Skin Cancer, NCCN Guidelines Version 1.2020, in NCCN Clinical Practice Guidelines in Oncology [Internet]. 2019. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx#site
- Wysong A, Newman J, Covington K, et al. Development and validation of a prognostic gene expression profile (GEP) for stratification of cutaneous squamous cell carcinoma (SCC) patients by 3-year risk of regional or distant metastases. Presented at American Society for Dermatologic Surgery Annual Meeting, October 2019, Chicago, IL.
- Ruiz ES, Karia PS, Besaw R, et al. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for cutaneous squamous cell carcinoma. JAMA Dermatol. 2019;155(7):819.
- Karia PS, Morgan FC, Califano JA, et al. Comparison of tumor classifications for cutaneous squamous cell carcinoma of the head and neck in the 7th vs 8th edition of the AJCC Cancer Staging Manual. JAMA Dermatol. 2018;154(2):175–181.
- Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149(4):402.
- Karia PS, Jambusaria-Pahlajani A, Harrington DP, et al. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women’s Hospital Tumor Staging for cutaneous squamous cell carcinoma. JCO. 2014;32(4):327–334.
- Canueto J, Burguillo J, Moyano-Bueno D, et al. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer Staging System and the Brigham and Women’s Hospital Alternative Staging System for cutaneous squamous cell carcinoma: implications for clinical practice. J Am Acad Dermatol. 2019;80(1):106–113.
- Wysong A, Newman JG, Covington KR, et al. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2020. DOI:10.1016/j.jaad.2020.04.088
- Farberg A, Hall M, Douglas L, et al. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1763284
- Thompson AK, Kelley BF, Prokop LJ, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(4):419–428.
- Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012;82(4):230–233.
- Haisma M, Plaat B, Bijl H, et al. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck. J Am Acad Dermatol. 2016;75(4):722–730.
- Stewart T, Saunders A. Risk factors for positive margins after wide local excision of cutaneous squamous cell carcinoma. J Dermatolog Treat. 2018;29(7):706–708.